Where are dopaminergic neurons found in the human brain and where do they project to?
Substantia nigra (most affected in PD): projects to caudate-putamen and striatum (“nigrostriatal pathway”, regulating motor function)
Ventral tegmental area and retrorubal field: project to striatum, limbic system, and PFC
Note that the above areas also project to the hippocampus in rats, and that DAn are also found in other areas throughout the CNS
Which brain region connections comprise the nigrostriatal pathway, and what is its function?
SN and its projections to the caudate-putamen and striatum; regulation of motor function
Describe 5 challenges associated with modelling sporadic PD in cell lines/animals.
Summarize key advances in PD pathophysiology discovered using SH-SY5Y cells and iPSC-derived dopaminergic neurons.
SH-SY5Y: Mitochondrial dysfunction, impaired autophagy
iPSC DAn: cell-cell transfer of aSyn, HDAC4 mislocalization, deregulated gene expression
Discuss the benefits and drawbacks of using LUHMES to model human PD epigenetics, comparing and contrasting to iPSCs.
Advantages:
- Midbrain origin
- Require differentiation, but not full reprogramming through embryonic state followed by differentiation
- Can expand easily
- Can synchronize cell cycle
- Express SNCA, NeuN, and DA-specific genes when differentiated; uptake and release DA
Limitations:
- Derived from a “normal” 8-week female embryo (vs patient)
- Clonal (benefit and drawback)
- Differentiation and culturing procedures still affect the epigenome, as with iPSCs
How is the LUHMES cell line proliferated and then differentiated to post-mitotic neurons?
Name 3-5 indicators that LUHMES cells have differentiated to mature dopaminergic neurons.
What happens to the SNCA locus during LUHMES differentiation, and what does this tell us about potential mechanisms for SNCA SNP variants in sporadic PD?
Increased H3K27ac at SNCA gene, in areas enriched for sPD-associated SNCA SNPs, associated with increased SNCA mRNA expression
Why are dopaminergic neurons particularly vulnerable to neurodegeneration?
No mitotic division (less opportunity to recover from toxins/aging); millions of axons far from cell body; generation of ROS from DA metabolism
What level of aSyn overexpression is seen in SNCA duplication/triplication carriers and REP1 allele carriers, and how does this compare to the level of aSyn overexpression in the LUHMES model used in Chapter 2 and the mouse model used in Chapter 3?
Triplication: ~2-2.5-fold upregulation of SNCA mRNA and protein in frontal cortex.
REP1: Longest allele has 2.5-fold overexpression of SNCA mRNA (reporter assay in SH-SY5Y). Shorter variants have 1.5-fold. Note that effect on expression is tissue-specific, and effect on PD risk is observed in White but not Japanese populations.
LUHMES: 4-fold mRNA, 6-fold protein (much higher than human!)
Mouse: 6-fold mRNA
What are the physiological consequences of WT aSyn overexpression in human PD patients and in cellular models of PD?
In SNCA triplication patients, PD has an earlier onset (30s-40s), progresses faster, and is more likely to have cognitive decline/dementia associated. LBs are found in the hypothalamus, nucleus basalis, and cortex, and neurodegeneration occurs in the nucleus basalis, cortex, and hippocampus.
SNCA triplication iPSCs have impaired differentiation capacity, neurite growth, and action potentials.
Overexpression of WT aSyn increases cytoplasmic inclusions in yeast and 293T cells, increases aSyn polymerization in yeast, results in Golgi fragmentation, miROS, and DNA damage in LUHMES.
How do the physiological effects of overexpressing WT and A30P aSyn differ in cellular models?
In 293Ts, A30P aSyn is less likely than WT to form cytoplasmic inclusions and more likely to oligomerize.
In H4 glioma cells, A30P aSyn is more likely than WT to be secreted.
In LUHMES, A30P aSyn does not induce DNA damage and miROS as much as WT aSyn, but does induce similar Golgi fragmentation.
Where is the SNCA gene located, how many amino acids are in the protein, and what is its weight?
On chromosome 4 (4q22.1). 140 AAs, 14 kDa.
Name 9 functions of aSyn, in the following categories: membrane-related, signalling, metabolic, and survival.
Membrane-related:
1. SNARE complex assembly & vesicle trafficking
2. Maintains PUFA levels at cell membranes
3. Antioxidant (monomeric aSyn binds lipid membranes)
4. Binds membrane-bound GPCRs, initiating cell signalling
Signalling:
5. Modulates calmodulin activity (2nd messenger for GRK5 kinase)
6. Chaperone with homology to 14-3-3 (phosphorylation of ERK, BAD, others…affecting neuronal differentiation)
Metabolic:
7. Regulation of glucose levels (glucose uptake, insulin secretion)
8. Dopamine biosynthesis regulation (inhibits TH, resulting in less dopamine; aSyn aggregation = LoF and too much dopamine)
Survival:
9. Suppression of apoptosis in DAn
Name two functions of aSyn which would likely be disrupted by the A30P mutation, and link these concepts to the results of Chapter 2 and [[Paiva et al. 2017]].
How do LRRK2 and PRKN initiate cellular disturbances that could result in aSyn aggregation?
LRRK2 interaction results in aSyn S129P, increased oligomerization
PRKN interaction attracts tubulin deposition, leading to cytoskeletal dysfunction
How can aSyn both increase and decrease dopamine levels in neurons?
Decrease: inhibits TH
Increase: when aggregated, LoF for TH inhibition
How does aSyn affect cell signalling (4 ways)?
Compare and contrast mechanisms of cytosolic and nuclear aSyn toxicity.
Cytosolic: Lewy bodies = LoF of normal aSyn activity; toxic GoF, overwhelming Ub-protease system. Associated with Golgi fragmentation and DNA damage.
Nuclear: deregulation of transcription and epigenetic marks (i.e., binding DNA, H3, HATs)
Describe 5 ways by which A30P aSyn differs from WT aSyn (structure/function).
What is colour correction and how is it conducted in GenomeStudio?
Normalizes the intensities of red/green colour channels for all probes based on intensities of control probes for each colour.
What is background subtraction and how is it conducted in GenomeStudio?
Background signal = 5th percentile of negative control probes, calculated separately in red and green channels. Subtracted from all probes in a channel after detection p-value calculation (probe intensity is constrained to be 0 or higher).
What are the 17 types of EPIC array control probes (7 categories) and how is their performance monitored via GenomeStudio?
In GenomeStudio, assessed visually in Controls Dashboard using scatterplots.
Staining (red/green), extension (red/green), restoration (bcDNA quality), hybridization (of synthetic target), target removal (stripping after base extension), bisulfite conversion (I and II, red and green), specificity (I and II), nonpolymorphic (overall assay performance, for each of the 4 nucleotides)
Summarize the 6 probe filtering checks applied to the LUHMES dataset and which filters were applied/skipped.
Applied separately in BS and oxBS data.
1. Remove SNP probes (59)
2. Remove X-hybridizing probes (~43K, >47bp homology to off-target site)
3. Kept polymorphic probes (clonal cell line)
4. Kept sex probes (clonal cell line)
5. Probes with >1% of samples with detection p-value > 0.05 (wateRmelon default)
6. Probes with >5% of samples with bead count < 3 (wateRmelon default)